Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00303
|
|||||
Drug Name |
L-leucine
|
|||||
Synonyms |
(2S)-2-amino-4-methylpentanoic acid; (2S)-alpha-leucine; (S)-(+)-Leucine; (S)-2-Amino-4-methylpentanoic acid; (S)-2-Amino-4-methylvaleric acid; (S)-Leucine; 2-amino-4-methylvaleric acid; 61-90-5; H-Leu-OH; L-(-)-2-Amino-4-methylpentanoic acid; L-Leuzin; L-Norvaline, 4-methyl-; L-alpha-Aminoisocaproic acid; L-leucin; LEUCINE, L-; Leucin; Leucin [German]; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; Leucine (VAN); Leucine [USAN:INN]; Leucinum; Leucinum [INN-Latin]; alpha-Aminoisocaproic acid; leu; leucine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Major depressive disorder [ICD11:6A70.3] | Phase 2 | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C6H13NO2
|
|||||
Canonical SMILES |
CC(C)CC(C(=O)O)N
|
|||||
InChI |
InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1
|
|||||
InChIKey |
ROHFNLRQFUQHCH-YFKPBYRVSA-N
|
|||||
CAS Number |
CAS 61-90-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 131.17 | Topological Polar Surface Area | 63.3 | ||
Heavy Atom Count | 9 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
-1.5
|
|||||
PubChem CID | ||||||
PubChem SID |
10317235
,10530134
,11459278
,11459418
,15146625
,15218991
,24874858
,24886442
,24896388
,24896488
,24896510
,24901619
,26651805
,29225114
,3423
,4253012
,46391850
,46392412
,46393330
,46507163
,46507999
,48416162
,49747925
,49835907
,49988821
,50108366
,57323191
,57581300
,57581304
,57651866
,57654329
,57654969
,57654972
,57654976
,595259
,6436525
,6436533
,6436536
,6436708
,7847098
,7888630
,80033595
,8025197
,81044540
,81055047
,8143308
,8153821
,832925
,838753
,841561
|
|||||
ChEBI ID |
ChEBI:15603
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | LAT1 | Transporter Info | L-type amino acid transporter 1 | Substrate | [2] | |
LAT3 | Transporter Info | L-type amino acid transporter 3 | Substrate | [3] | ||
LAT4 | Transporter Info | L-type amino acid transporter 4 | Substrate | [4] | ||
References | ||||||
1 | ClinicalTrials.gov (NCT03079297) Rapid Antidepressant Effects of Leucine | |||||
2 | Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009 Feb 6;136(3):521-34. | |||||
3 | Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003 Oct 31;278(44):43838-45. | |||||
4 | Anticipation of food intake induces phosphorylation switch to regulate basolateral amino acid transporter LAT4 (SLC43A2) function. J Physiol. 2019 Jan;597(2):521-542. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.